newsfilter
← Latest News
GlobeNewswire·

Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy

EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands Silo Pharma IP Portfolio SARASOTA, FL, April 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the